Vedolizumab Treatment May Reduce Steroid Burden and Improve Histology in Patients With Eosinophilic Gastroenteritis

Clin Gastroenterol Hepatol. 2018 Dec;16(12):1992-1994. doi: 10.1016/j.cgh.2018.03.024. Epub 2018 Mar 27.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Drug Utilization*
  • Enteritis / drug therapy*
  • Enteritis / pathology*
  • Eosinophilia / drug therapy*
  • Eosinophilia / pathology*
  • Female
  • Gastritis / drug therapy*
  • Gastritis / pathology*
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Steroids / therapeutic use*
  • Stomach / pathology
  • Treatment Outcome
  • Young Adult

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • Steroids
  • vedolizumab

Supplementary concepts

  • Eosinophilic enteropathy